DVA vs PROF · P/E 14, rev $12.82B vs rev $10.7M
DaVita HealthCare Partners Inc (DVA) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. PROF currently screens at market cap $238.7M.
Not investment advice. Open the DVA and PROF stock pages for the full models.
Not investment advice.